Objective: Laser phototherapy has been widely used to relieve pain for more than 30 years, but its efficacy remains controversial. To ascertain the overall effect of phototherapy on pain, we aggregated the literature and subjected the studies to statistical meta-analysis.
independently showed that monochromatic light can be an effective alternative to invasive needle acupuncture for pain relief. Yet, the value of phototherapy as a clinical armamentarium remains contentious, even though pain of head and neck origin and those associated with carpal tunnel syndrome were the first conditions that earned phototherapy the approval of the US Food and Drug Administration. World-wide laser phototherapy has been used to relieve arthritic pain, [3] [4] [5] tendonitis and related muscle injury, [6] [7] [8] [9] [10] [11] hemorrhoids, 12 carpal tunnel syndrome, [13] [14] [15] [16] neck pain, 17 low back pain, 18 and Raynaud syndrome. 19 The mechanisms for light-induced pain relief have begun to emerge. It has been postulated that photostimulation induces athermal photochemical reactions that alter the pain threshold of nociceptors. [20] [21] [22] Evidence abounds that phototherapy modulates inflammation by reducing prostaglandin E 2 concentrations, 23 inhibiting cyclo-oxygenase 2 in vitro, 23, 24 and reducing tumor necrosis factor a. 10, 25 It has also been shown that phototherapy enhances the release of endorphins. 26, 27 A fourth mechanism is that it enhances local hemodynamics, thus aiding the removal of pain-causing substances from the site of lesion. 28 , 29 Yet, another mechanism relates to its capacity to increase cellular oxygenation [30] [31] [32] and mitochondrial adenosine triphosphate 2, 33, 34 ; but how this mediates pain remains unclear.
Meta-analysis is a powerful statistical procedure for combining the results of 2 or more related studies to determine an overall treatment effect. 35 The resulting effect size of treatment yields a robust estimate of the true treatment effect compared with those derived from individual studies; permitting a better overview of the topic than would have been realized either by simply reviewing the literature, conducting a systematic review, or relying on the outcome of multiple studies. 36 These qualities render meta-analysis an objective quantitative review that can eliminate subjective assessment; thereby resolving most of the controversies concerning the clinical value of phototherapy on pain relief.
Earlier reviews and meta-analyses have shown that phototherapy relieves pain. 37, 38 However, these studies relied on articles published before 2000. Since 2002, when the Food and Drug Administration approved laser phototherapy for the temporary relief of pain associated with head and neck pain, carpal tunnel syndrome, and arthritis, interest in phototherapy for pain relief has been high. Moreover, there has been a shift from treatment with laser-based devices to treatment with light-emitting diodes, which unlike lasers lack coherence. On account of these developments, we aggregated peer-reviewed articles published between January 2000 and December 2007 and used statistical meta-analysis to test the null hypothesis that contemporary treatments with phototherapy have no significant positive effect on pain relief. In particular, we were interested in determining whether the current literature supports or refutes the use of phototherapy for pain relief.
MATERIALS AND METHODS

Participants and Design
Original research articles investigating the effects of phototherapy on pain relief and published between January 2000 and December 2007 were aggregated, coded, and used in this study. The articles were obtained from libraries and online sources, including Medline, PubMed, Ovid literature search engine, and Psychology Information (PsycInfo). The terms used to identify the articles included "laser therapy," "photo bio-modulation," "light therapy," "low level laser therapy," "phototherapy," "pain," "pain control," and "pain management." Secondary sources included papers cited by articles retrieved from the abovementioned sources, internet web pages, commercial search engines, and articles published in journals which were not available from the aforementioned databases.
Studies were included if they met the following criteria: (1) article was published in a peer-reviewed or scientific journal, (2) article was published between January 2000 and December 2007, (3) the study was completed in vivo using human participants only, (4) article stated or we were able to compute the following variables: power, power density, energy density, number of treatments given, duration of each treatment, frequency of treatment, beam and spot size, fluence (dose), size of the area treated, and mode of treatment (contact or noncontact mode), (5) the medical condition was clearly stated, (6) the study measured pain using a quantifiable scale or outcome, and (7) the wavelength and light source were identified. Articles were eliminated if any of the following exclusion criteria applied: (1) the study was conducted in vitro, (2) the article was a case study, (3) Cohen's d statistic could not be calculated from the data provided, or (4) members of the research team were unable to translate the article into English to compute Cohen's d.
Pilot Reliability Study and Data Coding
A coding form with a list of relevant parameters and related information was developed as shown in Table 1 . Data from the studies that met inclusion criteria were then collected to establish a data pool. To ensure data accuracy, 6 raters were first trained; then a pilot study was conducted to determine the level of agreement among them as they ascertained the presence or absence of the parameters detailed in Table 1 , and as they calculated the treatment effect sizes, that is, Cohen's d, from an initial set of 10 randomly selected studies. Raters were retrained with new sets of articles and retested for reliability until at least 90% agreement was attained.
Determination of Effect Size
Effect sizes were calculated using the formulae for computing Cohen's d statistic. 35, 36 Cohen's d is defined as the difference between the means of the experimental group and the comparison group divided by the SD of the comparison group as follows:
Where d stands for the effect size, x 1 is the mean of the treated group, x 2 is the mean of the comparison group, and SD comparison is the SD of the comparison group.
Where means and SDs were not reported but data was presented as percentages, a d value was calculated by first finding the associated t value with the following formula:
Where P 2 is the percent change of the treatment group, P 1 is the percent change of the comparison group, N 2 is the number of participants in the treated group, and N 1 is the number of participants in the comparison group. The t value calculated was then converted to a d value using the following formula 35, 36 :
Where d is the effect size, t is the t value, and df is the degree of freedom. The degree of freedom was determined with the formula 36 :
df¼ N 1 þ N 2 À 2 N 1 and N 2 are the numbers of participants treated in the comparison group and the treated group, respectively.
The overall mean effect size was calculated by summing the d values obtained independently from each study and then divided by the total number of d values as follows: 
Grubb's Extreme Studentized Deviation Test for Critical Outliers
To identify outlying d values, Grubb's test 39 or critical outliers was performed on the pool of calculated d values using the following formula:
SD Where z is the z score for each individual d value, d average is the mean effect size, and SD is the SD of d average . The z score was then compared with a critical z value obtained from Grubb's critical-z Table. In further analysis, the effect sizes obtained from studies with repeated measurements of the same outcome variable were averaged to minimize undue influence of any one study on the overall effect size. 40 For example, if pain was measured on the same participants at 5 different time intervals in a particular study, the d values obtained were averaged to yield 1 d value instead of 5. 40 Finally, the overall d value obtained was considered small, medium, or large in accordance with the guideline provided by Cohen. 36 According to Cohen, 36 the values of 0.2, 0.5, and 0.8 indicate a small, medium, and large average effect size, respectively.
Calculation of the Fail-safe Number
Considering the likelihood that our meta-analysis did not include every relevant published report, we computed the fail-safe number (N fs ) associated with the overall d value obtained. From a statistical point of view, this is the number of nonsignificant studies that would be necessary to reduce the effect size resulting from this analysis to a nonsignificant value. Practically, it is the number of additional studies with effect sizes below our set criterion value that would have to be included in the metaanalysis to negate the outcome of this study. A set criterion value of 0.05 was used, statistical significance was set to 0.05, and the N fs was calculated with the following formula:
Where N is the number of studies in the meta-analysis, d is the average effect size for the studies used, and d c is the criterion value selected. For this meta-analysis, d c was set to 0.05, the value of a nonsignificant small effect size.
RESULTS
We identified 22 articles from the 59 peer-reviewed papers that met the inclusion criteria. We excluded 9 papers from the analysis immediately because they were reviews, case studies, meta-analyses, lacked a control group, or did not measure pain on a quantifiable scale. An additional 28 papers were experimental or quasi-experimental; however, they too were excluded, as they lacked the numerical data needed to calculate treatment effect sizes. In several studies, data were presented as charts without descriptive summary data. Nonetheless, further analysis of these 28 papers showed that 23 (82.1%) demonstrated that phototherapy relieves pain; only 5 did not. In contrast, of the 22 articles included in our analysis, 13 (59.1%) found phototherapy to be effective in relieving pain, 9 did not; indicating that there was no bias in excluding the 28 studies from this analysis. Indeed, had it been possible to include the entire 50 experimental or quasi-experimental studies in the analysis, the outcome would have been more positive than reported below; as 36 (72%) of the 50 studies showed phototherapy to be effective in relieving pain, compared with the 59.1% of the studies used in this analysis ( Table 2) . Ninety-six computable effect sizes were calculated from the 22 studies used. Fifty-two effect sizes were obtained when multiple d values from the same study were averaged to account for repeated measurements of the same variable over time, as detailed above. The overall mean effect size obtained from the 52 effect sizes was +0.84 (95% confidence interval 0.44-1.23). This finding indicates that phototherapy is highly effective for pain relief. The fail-safe number corresponding to this overall mean effect size was 348; meaning that 348 additional studies reporting a neutral or negative effect of phototherapy on pain would be needed to invalidate the outcome of this analysis (Table 3) .
To permit a comparison of our results with those of Enwemeka et al 38 who used 0.10 as their set criteria, the fail-safe number was recalculated using 0.10 as the set criterion instead of the commonly used 0.05. The resulting fail-safe number was 163; a high number which again confirms that the likelihood of overturning the significant treatment effect size (+0.84) is minute.
When we removed the lone positively high outlying d value from the analysis, the resulting d value was 0.66 (95% confidence interval +0.46-+0.86). This finding again shows that phototherapy has a significant positive effect on pain relief. The fail-safe number associated with this effect size was 256 (118, if 0.10 is used as the set criterion).
To put our findings in perspective, we have included the conditions treated and the variables measured in the studies that were included in this analysis in Table 4 . Similarly, the source of light, wavelength, power, power density, and energy density for each study are presented in Table 5 , and Table 6 outlines the number, frequency, and duration of treatments, specific outcome data, and effect sizes for each study.
DISCUSSION
It is well recognized in meta-analysis that a treatment effect of +0.2 signifies a small effect size, +0.4 a medium effect size, and a value of +0.8 or greater indicates a large effect size of treatment. 36 Thus, the large effect size (+0.84) obtained in this analysis signifies that phototherapy is a highly effective form of treatment for pain relief. Even with our conservative approach of removing a high outlying d value, the treatment effect size remained significant. These results are consistent with the findings of Enwemeka et al 38 who reported a treatment effect size of +1.11 and a fail-safe number of 41 in their meta-analysis of articles published during the 30 years before year 2000. It should be noted that Enwemeka et al 38 did not control for outlying d values; moreover, their analysis was based on 9 articles that met their inclusion criteria. The effect size obtained in this meta-analysis would have likely been Ga-Ar indicates gallium argon; Ga-As, gallium arsenide; Ga-As-Al, gallium arsenide aluminum; IR, infra red; LLL, low level laser; R, red. higher than +0.84, had it been possible to include the 28 experimental studies that were excluded from this study. Twenty-three (82.1%) of the 28 papers excluded showed phototherapy to be significantly effective in pain reduction (Table 2) ; compared with 59.1% of the studies used in this analysis.
Compared with the 9 effect sizes computed from the 9 studies identified in the earlier study, 38 52 effect sizes were computed from 22 articles in this study. The higher number of computable effect sizes and the larger number of relevant articles suggests a higher level of sophistication of articles published since 2000. Most contemporary articles measured pain outcomes at several time points or used multiple scales to estimate pain. Even after accounting for repeated measurements of the same outcome variable, the average number of computed effect sizes remained high. Furthermore, the total number of articles (22) with computable effect sizes published between January 2000 and December 2007 is more than twice the number of peer-reviewed articles (9) with computable effect sizes in the study by Enwemeka et al 38 which covered a 30-year period. This observation, which indicates that more articles have been published since 2000, also reflects the increasing acceptance of phototherapy as a clinical tool for pain relief.
Our findings strengthen earlier reports, which indicate that phototherapy is beneficial for pain relief, regardless of etiology.
3,4,6,7,17-19,27,37,38,41-43 For example, Brosseau et al 37 reviewed 13 clinical trials that examined the effects of laser phototherapy on pain relief in persons with either osteoarthritis or rheumatoid arthritis. They showed that, in patients with rheumatoid arthritis, phototherapy reduced pain by 70% and morning stiffness by 27.5 minutes relative to placebo; but functional assessment, range of motion, and local swelling did not differ between the 2 groups. The result for osteoarthritis was inconclusive, as the outcome of treatment seemed dependent on the parameters of treatment. Similarly, as detailed above, Enwemeka et al 38 used statistical meta-analysis to demonstrate that treatment with laser phototherapy moderately relieves pain of various etiologies.
The exact mechanisms by which phototherapy relieves pain continue to evolve. It has been shown that phototherapy increases local and systemic microcirculation thereby reducing swelling and pain. The increased blood flow is associated with nitric oxide synthesis. 8 Others have shown that phototherapy relieves pain by modulating key mediators of inflammation-for example, reducing the level of prostaglandin E 2 and inhibiting cyclo-oxygenase 23, 24 similar to the effects of nonsteroidal anti-inflammatory drugs and steroids. Furthermore, it has been postulated that photostimulation induces athermal photochemical reactions that modulate nerve transmission, thereby altering the pain threshold of nociceptors. [20] [21] [22] In addition, there is evidence that phototherapy enhances the release of endorphins-the bodies endogenous pain relievers. 26, 27 It is possible that a combination of these and other mechanisms are involved in the effect of phototherapy on pain relief. Thus, further studies are needed to clarify the mechanisms involved. As our study was limited to articles published in English, we recommend that future meta-analysis include articles published in other languages. Such effort could yield a significantly greater pool of articles even though the relatively few foreign language articles we examined had such limited information that it was not possible to compute effect sizes from them. Future studies on the effects of phototherapy on pain should include functional outcome instruments to bridge the gap between pain and its effect on function. As observed in Table 6 , only 2 of the studies used functional-based outcome scales with the majority using visual analog pain scales.
Our findings warrant the conclusion that phototherapy effectively relieves pain of various etiologies; suggesting that it could be a valuable addition to contemporary pain management armamentarium. This finding does not suggest, however, that phototherapy should be used in isolation of other treatment strategies for musculoskeletal conditions. In contrast, standards of care for acute and chronic musculoskeletal pain such as the ones established by the Bone and Joint Decade Task Force 44 place an emphasis on multidisciplinary intervention strategies and self-management.
